269 related articles for article (PubMed ID: 31028563)
21. Celastrol Reduces Obesity in MC4R Deficiency and Stimulates Sympathetic Nerve Activity Affecting Metabolic and Cardiovascular Functions.
Saito K; Davis KC; Morgan DA; Toth BA; Jiang J; Singh U; Berglund ED; Grobe JL; Rahmouni K; Cui H
Diabetes; 2019 Jun; 68(6):1210-1220. PubMed ID: 30894367
[TBL] [Abstract][Full Text] [Related]
22. Leptin and hypertension in obesity.
Bravo PE; Morse S; Borne DM; Aguilar EA; Reisin E
Vasc Health Risk Manag; 2006; 2(2):163-9. PubMed ID: 17319461
[TBL] [Abstract][Full Text] [Related]
23. The sympathetic nervous system and obesity: role in aetiology and treatment.
Snitker S; Macdonald I; Ravussin E; Astrup A
Obes Rev; 2000 May; 1(1):5-15. PubMed ID: 12119646
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms in obesity-related hypertension: role of insulin and catecholamines.
Krieger DR; Landsberg L
Am J Hypertens; 1988 Jan; 1(1):84-90. PubMed ID: 3285861
[TBL] [Abstract][Full Text] [Related]
25. Obesity, hypertension, and sympathetic nervous system activity.
Corry DB; Tuck ML
Curr Hypertens Rep; 1999; 1(2):119-26. PubMed ID: 10981052
[TBL] [Abstract][Full Text] [Related]
26. Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.
Kalil GZ; Haynes WG
Hypertens Res; 2012 Jan; 35(1):4-16. PubMed ID: 22048570
[TBL] [Abstract][Full Text] [Related]
27. Role of hindbrain melanocortin-4 receptor activity in controlling cardiovascular and metabolic functions in spontaneously hypertensive rats.
do Carmo JM; da Silva AA; Hall JE
J Hypertens; 2015 Jun; 33(6):1201-6. PubMed ID: 25668357
[TBL] [Abstract][Full Text] [Related]
28. Obesity hypertension: role of leptin and sympathetic nervous system.
Hall JE; Hildebrandt DA; Kuo J
Am J Hypertens; 2001 Jun; 14(6 Pt 2):103S-115S. PubMed ID: 11411745
[TBL] [Abstract][Full Text] [Related]
29. Neural mechanisms and management of obesity-related hypertension.
Esler MD; Eikelis N; Lambert E; Straznicky N
Curr Cardiol Rep; 2008 Nov; 10(6):456-63. PubMed ID: 18950554
[TBL] [Abstract][Full Text] [Related]
30. Activation of the melanocortin-4 receptor causes enhanced excitation in presympathetic paraventricular neurons in obese Zucker rats.
Ye ZY; Li DP
Regul Pept; 2011 Jan; 166(1-3):112-20. PubMed ID: 20937332
[TBL] [Abstract][Full Text] [Related]
31. Central proopiomelanocortin but not neuropeptide Y mediates sympathoexcitation and hypertension in fat fed conscious rabbits.
Barzel B; Lim K; Davern PJ; Burke SL; Armitage JA; Head GA
J Hypertens; 2016 Mar; 34(3):464-73; discussion 473. PubMed ID: 26820476
[TBL] [Abstract][Full Text] [Related]
32. Insulin and the sympathetic nervous system in the pathophysiology of hypertension.
Landsberg L
Blood Press Suppl; 1996; 1():25-9. PubMed ID: 9162434
[TBL] [Abstract][Full Text] [Related]
33. Melanocortin-4 receptor-deficient mice are not hypertensive or salt-sensitive despite obesity, hyperinsulinemia, and hyperleptinemia.
Tallam LS; Stec DE; Willis MA; da Silva AA; Hall JE
Hypertension; 2005 Aug; 46(2):326-32. PubMed ID: 16027245
[TBL] [Abstract][Full Text] [Related]
34. Obesity-associated hypertension: new insights into mechanisms.
Rahmouni K; Correia ML; Haynes WG; Mark AL
Hypertension; 2005 Jan; 45(1):9-14. PubMed ID: 15583075
[TBL] [Abstract][Full Text] [Related]
35. The global epidemic of obesity: are we becoming more sympathetic?
Davy KP
Curr Hypertens Rep; 2004 Jun; 6(3):241-6. PubMed ID: 15128479
[TBL] [Abstract][Full Text] [Related]
36. Leptin and the central neural mechanisms of obesity hypertension.
Rahmouni K; G Haynes W
Drugs Today (Barc); 2002 Dec; 38(12):807-17. PubMed ID: 12582470
[TBL] [Abstract][Full Text] [Related]
37. Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques.
Kievit P; Halem H; Marks DL; Dong JZ; Glavas MM; Sinnayah P; Pranger L; Cowley MA; Grove KL; Culler MD
Diabetes; 2013 Feb; 62(2):490-7. PubMed ID: 23048186
[TBL] [Abstract][Full Text] [Related]
38. New developments in the pathogenesis of obesity-induced hypertension.
Kotsis V; Nilsson P; Grassi G; Mancia G; Redon J; Luft F; Schmieder R; Engeli S; Stabouli S; Antza C; Pall D; Schlaich M; Jordan J;
J Hypertens; 2015 Aug; 33(8):1499-508. PubMed ID: 26103132
[TBL] [Abstract][Full Text] [Related]
39. Sympathetic nerves and hypertension in stress, sleep apnea, and caregiving.
Ziegler MG; Milic M
Curr Opin Nephrol Hypertens; 2017 Jan; 26(1):26-30. PubMed ID: 27755119
[TBL] [Abstract][Full Text] [Related]
40. Factors Responsible for Obesity-Related Hypertension.
Lim K; Jackson KL; Sata Y; Head GA
Curr Hypertens Rep; 2017 Jul; 19(7):53. PubMed ID: 28551830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
